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Purpose: Atypical antipsychotic drugs such as olanzapine and clozapine induce significant
weight gain and obesity in schizophrenia and allied disorders. Prenatal infection is considered
to be a severe impact to brain development which can lead to offspring developing late onset
behavioural abnormalities. These abnormalities resemble some aspects of schizophrenia. This
study aims to develop a rodent model mimicking patients of schizophrenia with metabolic
syndrome after chronic treatment with olanzapine.
Methods: Pregnant SD rats were injected with saline, PolyI:C (polyinosinic-polycytidylic
acid, 8mg/kg), LPS (lipopolysaccharide, 100 microgram/kg) from gestation day 15 and 16.
Each group was subdivided into a control and olanzapine group, and treated for 5 weeks from
13 weeks of age. All rats throughout the experiment were fed lab chow ad libitum. Body
weight and food and water intake were measured twice a week.
Results: Prenatal PolyI:C and LPS rats gained weight quickly and developed obesity after
olanzapine administration. The final body weight of the prenatal LPS group with olanzapine
treatment was higher than the saline control (p=0.002) and LPS control groups (p=0.004)
respectively. Prenatal infection with LPS in addition to olanzapine significantly increased
peri-ovarian adipose weight (p=0.001). Analysis of hypothalamic neuropeptides relevant to
body weight control and metabolism is currently ongoing.
Conclusion: For the first time, the viral and bacterial prenatal infection models successfully
replicate antipsychotic drug induced obesity and metabolic syndrome in SD rats. This model
represents the diseased condition in humans brought on by prenatal viral or bacterial infection.
This animal model will be used to study the mechanism of antipsychotic drug induced obesity
and metabolic side effects, and to identify therapeutic targets for treatment.

